Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World

5 Oct 2017

Abstract excerpt

With the problem of multidrug-resistant Gram-negative pathogens becoming increasingly dire, new strategies are needed to protect and treat infected patients. Though abandoned in the past, monoclonal antibody therapy against Gram-negative bacteria remains a potential solution and has potential advantages over the broad-spectrum antibiotics they were once replaced by. This Perspective reviews the prospect of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Bacteriophages and microbial interactions
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28989972
DOI: 10.1128/msphere.00397-17

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic WorldPMID 28989972Read ↗

Combating multidrug-resistant Gram-negative bacterial infectionsSemantic proximity Read ↗

Current and future perspectives in the treatment of multidrug-resistant Gram-negative infectionsSemantic proximity Read ↗

Developments on antibiotics for multidrug resistant bacterial Gram-negative infectionsSemantic proximity Read ↗

Development of Antimicrobial Agents in the Era of New and Reemerging Infectious Diseases and Increasing Antibiotic ResistanceSemantic proximity Read ↗

Targeted Anti Bacterial TherapySemantic proximity Read ↗

Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnosticsSemantic proximity Read ↗

New β-lactam antibiotics and β-lactamase inhibitorsSemantic proximity Read ↗

Development of Peptides that Inhibit Aminoglycoside-Modifying Enzymes and β-Lactamases for Control of Resistant BacteriaSemantic proximity Read ↗

Current concepts in antibiotic-resistant gram-negative bacteria.Semantic proximity Read ↗

Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical UseSemantic proximity Read ↗

Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitorsSemantic proximity Read ↗

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative BacteriaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.